Kurata, Morito
Yamamoto, Kouhei
Moriarity, Branden S.
Kitagawa, Masanobu
Largaespada, David A.
Article History
Received: 30 June 2017
Revised: 3 October 2017
Accepted: 4 October 2017
First Online: 20 November 2017
Compliance with ethical standards
:
: D.A.L. is co-owner and advisor to NeoClone Biotechnology, Inc., B-MoGen Biotechnologies Inc., and Discovery Genomics, Inc. No resources or personnel from any company were involved in this research in any way. The remaining authors declare that they have no competing interests.